What is the share price of Mercury Laboratories Ltd (MERCURYLAB) today?
The share price of MERCURYLAB as on 20th June 2025 is ₹829.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Mercury Laboratories Ltd (MERCURYLAB) share?
The past returns of Mercury Laboratories Ltd (MERCURYLAB) share are- Past 1 week: -1.52%
- Past 1 month: 0.86%
- Past 3 months: -0.56%
- Past 6 months: -9.87%
- Past 1 year: -6.64%
- Past 3 years: 92.37%
- Past 5 years: 122.10%
What are the peers or stocks similar to Mercury Laboratories Ltd (MERCURYLAB)?
The peers or stocks similar to Mercury Laboratories Ltd (MERCURYLAB) include:What is the dividend yield % of Mercury Laboratories Ltd (MERCURYLAB) share?
The current dividend yield of Mercury Laboratories Ltd (MERCURYLAB) is 0.41.What is the market cap of Mercury Laboratories Ltd (MERCURYLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mercury Laboratories Ltd (MERCURYLAB) is ₹102 Cr as of 20th June 2025.What is the 52 week high and low of Mercury Laboratories Ltd (MERCURYLAB) share?
The 52-week high of Mercury Laboratories Ltd (MERCURYLAB) is ₹1190 and the 52-week low is ₹736.What is the PE and PB ratio of Mercury Laboratories Ltd (MERCURYLAB) stock?
The P/E (price-to-earnings) ratio of Mercury Laboratories Ltd (MERCURYLAB) is 32.48. The P/B (price-to-book) ratio is 2.01.Which sector does Mercury Laboratories Ltd (MERCURYLAB) belong to?
Mercury Laboratories Ltd (MERCURYLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Mercury Laboratories Ltd (MERCURYLAB) shares?
You can directly buy Mercury Laboratories Ltd (MERCURYLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Mercury Laboratories Ltd
MERCURYLAB Share Price
MERCURYLAB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MERCURYLAB Performance & Key Metrics
MERCURYLAB Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
32.59 | 2.01 | 0.41% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
35.65 | 6.55 | 0.83% |
MERCURYLAB Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
MERCURYLAB Company Profile
Mercury Laboratories Limited is a pharmaceutical company engaged in the manufacturing of pharmaceuticals, medicinal drugs and formulations.
MERCURYLAB Forecast
MERCURYLAB Forecasts
MERCURYLAB
MERCURYLAB
Income
Balance Sheet
Cash Flow
MERCURYLAB Income Statement
MERCURYLAB Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 48.37 | 52.28 | 56.56 | 58.12 | 69.48 | 58.86 | 77.05 | 76.65 | 76.17 | 76.17 | ||||||||||
Raw Materials | 19.80 | 24.55 | 24.59 | 24.80 | 31.01 | 23.88 | 30.96 | 30.45 | 68.08 | 68.09 | ||||||||||
Power & Fuel Cost | 1.18 | 1.24 | 1.31 | 1.62 | 1.59 | 1.15 | 1.62 | 1.87 | ||||||||||||
Employee Cost | 6.90 | 7.34 | 7.83 | 9.30 | 9.80 | 12.50 | 14.24 | 14.50 | ||||||||||||
Selling & Administrative Expenses | 11.25 | 13.38 | 12.02 | 12.12 | 12.40 | 11.75 | 15.53 | 14.56 | ||||||||||||
Operating & Other expenses | 2.18 | 0.94 | 4.05 | 3.26 | 4.21 | 1.65 | 4.41 | 5.15 | ||||||||||||
EBITDA | 7.06 | 4.83 | 6.76 | 7.02 | 10.47 | 7.93 | 10.29 | 10.12 | 8.09 | 8.08 | ||||||||||
Depreciation/Amortization | 1.29 | 1.47 | 1.63 | 1.87 | 1.92 | 2.45 | 2.48 | 2.82 | 2.88 | 2.88 | ||||||||||
PBIT | 5.77 | 3.36 | 5.13 | 5.15 | 8.55 | 5.48 | 7.81 | 7.30 | 5.21 | 5.20 | ||||||||||
Interest & Other Items | 0.89 | 0.91 | 1.09 | 0.82 | 0.64 | 0.45 | 0.36 | 0.38 | 0.55 | 0.55 | ||||||||||
PBT | 4.88 | 2.45 | 4.04 | 4.33 | 7.91 | 5.03 | 7.45 | 6.92 | 4.66 | 4.65 | ||||||||||
Taxes & Other Items | 2.19 | 0.44 | 1.21 | 1.10 | 2.57 | 1.47 | 1.86 | 1.27 | 1.52 | 1.52 | ||||||||||
Net Income | 2.69 | 2.01 | 2.83 | 3.23 | 5.34 | 3.56 | 5.59 | 5.65 | 3.14 | 3.13 | ||||||||||
EPS | 22.42 | 16.75 | 23.58 | 26.92 | 44.50 | 29.67 | 46.58 | 47.08 | 26.21 | 26.08 | ||||||||||
DPS | 1.50 | 1.50 | 1.50 | 2.00 | 3.50 | 3.50 | 3.50 | 3.50 | 3.50 | 3.50 | ||||||||||
Payout ratio | 0.07 | 0.09 | 0.06 | 0.07 | 0.08 | 0.12 | 0.08 | 0.07 | 0.13 | 0.13 |
MERCURYLAB Company Updates
MERCURYLAB Stock Peers
MERCURYLAB Past Performance & Peer Comparison
MERCURYLAB Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Mercury Laboratories Ltd | 32.48 | 2.01 | 0.41% |
Sun Pharmaceutical Industries Ltd | 36.18 | 5.89 | 0.97% |
Cipla Ltd | 22.95 | 4.51 | 1.07% |
Dr Reddy's Laboratories Ltd | 19.32 | 3.87 | 0.61% |
MERCURYLAB Stock Price Comparison
Compare MERCURYLAB with any stock or ETFMERCURYLAB Holdings
MERCURYLAB Shareholdings
MERCURYLAB Promoter Holdings Trend
MERCURYLAB Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
MERCURYLAB Institutional Holdings Trend
MERCURYLAB Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
MERCURYLAB Shareholding Pattern
MERCURYLAB Shareholding Pattern
MERCURYLAB Shareholding History
MERCURYLAB Shareholding History
smallcases containing MERCURYLAB stock
smallcases containing MERCURYLAB stock
Looks like this stock is not in any smallcase yet.
MERCURYLAB Events
MERCURYLAB Events
MERCURYLAB Dividend Trend
MERCURYLAB has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.41%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.12 every year
Dividends
Corp. Actions
Announcements
Legal Orders
MERCURYLAB Dividend Trend
MERCURYLAB has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.41%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.12 every year
MERCURYLAB Upcoming Dividends
MERCURYLAB Upcoming Dividends
No upcoming dividends are available
MERCURYLAB Past Dividends
MERCURYLAB Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2024
Dividend/Share
₹3.50
Ex DateEx Date
Sep 20, 2024
Cash Dividend
Ex DateEx DateSep 20, 2023
Dividend/Share
₹3.50
Ex DateEx Date
Sep 20, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Dividend/Share
₹3.50
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateSep 20, 2021
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2021
Cash Dividend
Ex DateEx DateFeb 22, 2021
Dividend/Share
₹1.50
Ex DateEx Date
Feb 22, 2021
MERCURYLAB Stock News & Opinions
MERCURYLAB Stock News & Opinions
Net profit of Mercury Laboratories declined 41.88% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 1.91 crore during the previous quarter ended March 2024. Sales rose 18.94% to Rs 20.66 crore in the quarter ended March 2025 as against Rs 17.37 crore during the previous quarter ended March 2024. For the full year,net profit declined 44.42% to Rs 3.14 crore in the year ended March 2025 as against Rs 5.65 crore during the previous year ended March 2024. Sales declined 0.61% to Rs 75.10 crore in the year ended March 2025 as against Rs 75.56 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales20.6617.37 19 75.1075.56 -1 OPM %10.3115.31 -9.3511.95 - PBDT2.182.97 -27 7.549.74 -23 PBT1.452.25 -36 4.666.92 -33 NP1.111.91 -42 3.145.65 -44 Powered by Capital Market - Live
Mercury Laboratories announced that the 44th Annual General Meeting(AGM) of the company will be held on 13 August 2025.Powered by Capital Market - Live
Mercury Laboratories announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 35%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live
Net profit of Mercury Laboratories declined 4.03% to Rs 1.19 crore in the quarter ended December 2024 as against Rs 1.24 crore during the previous quarter ended December 2023. Sales rose 14.38% to Rs 19.57 crore in the quarter ended December 2024 as against Rs 17.11 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales19.5717.11 14 OPM %10.1213.03 - PBDT2.382.31 3 PBT1.641.59 3 NP1.191.24 -4 Powered by Capital Market - Live
Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
Net profit of Mercury Laboratories declined 66.89% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 1.51 crore during the previous quarter ended September 2023. Sales declined 20.08% to Rs 18.19 crore in the quarter ended September 2024 as against Rs 22.76 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales18.1922.76 -20 OPM %7.1510.94 - PBDT1.362.74 -50 PBT0.652.03 -68 NP0.501.51 -67 Powered by Capital Market - Live
Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Mercury Laboratories announced that the 43th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Net profit of Mercury Laboratories declined 66.00% to Rs 0.34 crore in the quarter ended June 2024 as against Rs 1.00 crore during the previous quarter ended June 2023. Sales declined 8.95% to Rs 16.68 crore in the quarter ended June 2024 as against Rs 18.32 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales16.6818.32 -9 OPM %9.659.12 - PBDT1.621.74 -7 PBT0.921.06 -13 NP0.341.00 -66 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 6.27%, vs industry avg of 9.03%
Over the last 5 years, market share decreased from 0.03% to 0.02%
Over the last 5 years, net income has grown at a yearly rate of 14.83%, vs industry avg of 15.28%